Prostaglandin E2 inhibits transforming growth factor beta 1-mediated induction of collagen alpha 1(I) in hepatic stellate cells.

[1]  S. Narumiya,et al.  Prostaglandin E2–EP4 signaling initiates skin immune responses by promoting migration and maturation of Langerhans cells , 2003, Nature Medicine.

[2]  A. Knox,et al.  Effect of bradykinin, TGF-β1, IL-1β, and hypoxia on COX-2 expression in pulmonary artery smooth muscle cells , 2002 .

[3]  V. Paradis,et al.  Effects and Regulation of Connective Tissue Growth Factor on Hepatic Stellate Cells , 2002, Laboratory Investigation.

[4]  Hyung-Suk Kim,et al.  A genetically clamped renin transgene for the induction of hypertension , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[5]  S. Dooley,et al.  Roles of TGF-beta in hepatic fibrosis. , 2002, Frontiers in bioscience : a journal and virtual library.

[6]  T. Sugimura,et al.  Chemopreventive effects of ONO-8711, a selective prostaglandin E receptor EP(1) antagonist, on breast cancer development. , 2001, Carcinogenesis.

[7]  M. Monden,et al.  Differential expression of cyclooxygenase‐2 (COX‐2) in human bile duct epithelial cells and bile duct neoplasm , 2001, Hepatology.

[8]  F. Marra,et al.  Cytokine Receptors and Signaling in Hepatic Stellate Cells , 2001, Seminars in liver disease.

[9]  R. Langenbach,et al.  Why there are two cyclooxygenase isozymes. , 2001, The Journal of clinical investigation.

[10]  G. Laurent,et al.  Cyclooxygenase-2 deficiency results in a loss of the anti-proliferative response to transforming growth factor-beta in human fibrotic lung fibroblasts and promotes bleomycin-induced pulmonary fibrosis in mice. , 2001, The American journal of pathology.

[11]  A. J. Valente,et al.  Agonist‐specific regulation of monocyte chemoattractant protein‐1 expression by cyclooxygenase metabolites in hepatic stellate cells , 2001, Hepatology.

[12]  A. Gentilini,et al.  Nitrovasodilators inhibit platelet-derived growth factor-induced proliferation and migration of activated human hepatic stellate cells. , 2000, Gastroenterology.

[13]  A. Knox,et al.  TGF-β1 stimulates IL-8 release, COX-2 expression, and PGE2release in human airway smooth muscle cells , 2000 .

[14]  P. Isakson,et al.  Celecoxib versus diclofenac in long-term management of rheumatoid arthritis: randomised double-blind comparison , 1999, The Lancet.

[15]  V. Koteliansky,et al.  In vivo inhibition of rat stellate cell activation by soluble transforming growth factor beta type II receptor: a potential new therapy for hepatic fibrosis. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[16]  T. Taguchi,et al.  The possible role of colligin/HSP47, a collagen-binding protein, in the pathogenesis of human and experimental fibrotic diseases. , 1999, Histology and histopathology.

[17]  S. Friedman,et al.  Liver fibrogenesis and the role of hepatic stellate cells: New insights and prospects for therapy , 1999, Journal of gastroenterology and hepatology.

[18]  L. Fontana,et al.  Transforming growth factor β1 induces the expression of α1(i) procollagen mRNA by a hydrogen peroxide‐C/EBPβ‐dependent mechanism in rat hepatic stellate cells , 1999 .

[19]  A. Mallat,et al.  Platelet-derived Growth Factor-BB and Thrombin Generate Positive and Negative Signals for Human Hepatic Stellate Cell Proliferation , 1998, The Journal of Biological Chemistry.

[20]  A. Mallat,et al.  Role of NF-κB in the Antiproliferative Effect of Endothelin-1 and Tumor Necrosis Factor-α in Human Hepatic Stellate Cells , 1998, The Journal of Biological Chemistry.

[21]  P. Desmond,et al.  Sequential increases in the intrahepatic expression of epidermal growth factor, basic fibroblast growth factor, and transforming growth factor β in a bile duct ligated rat model of cirrhosis , 1997, Hepatology.

[22]  William L. Smith,et al.  Prostaglandin Endoperoxide H Synthases (Cyclooxygenases)-1 and −2* , 1996, The Journal of Biological Chemistry.

[23]  D. Brenner,et al.  Growth inhibitory properties of endothelin-1 in activated human hepatic stellate cells: a cyclic adenosine monophosphate-mediated pathway. Inhibition of both extracellular signal-regulated kinase and c-Jun kinase and upregulation of endothelin B receptors. , 1996, The Journal of clinical investigation.

[24]  J. Otto,et al.  Photolabeling of Prostaglandin Endoperoxide H Synthase-1 with 3-Trifluoro-3-(m-Iiodophenyl)diazirine as a Probe of Membrane Association and the Cyclooxygenase Active Site (*) , 1996, The Journal of Biological Chemistry.

[25]  R. Langenbach,et al.  Prostaglandin synthase 2 gene disruption causes severe renal pathology in the mouse , 1995, Cell.

[26]  M. Sporn,et al.  Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[27]  M. Fukumoto,et al.  Coexpression of the collagen-binding stress protein HSP47 gene and the alpha 1(I) and alpha 1(III) collagen genes in carbon tetrachloride-induced rat liver fibrosis. , 1994, The Journal of clinical investigation.

[28]  F. Thaiss,et al.  The effect of prostaglandin E2 on mRNA expression and secretion of collagens I, III, and IV and fibronectin in cultured rat mesangial cells. , 1994, Journal of the American Society of Nephrology : JASN.

[29]  S. Friedman.  The Cellular Basis of Hepatic Fibrosis -- Mechanisms and Treatment Strategies , 1993 .

[30]  J. Prieto,et al.  Transforming growth factors beta 1 and alpha in chronic liver disease. Effects of interferon alfa therapy. , 1991, The New England journal of medicine.

[31]  R. Young,et al.  Effects of selective prostaglandin EP4 receptor antagonist on osteoclast formation and bone resorption in vitro. , 2002, Bone.

[32]  D. Dixon,et al.  Transforming growth factor-beta1 enhances Ha-ras-induced expression of cyclooxygenase-2 in intestinal epithelial cells via stabilization of mRNA. , 2000, The Journal of biological chemistry.